The DOI matches its Crossref record.
Mucopolysaccharidosis I, II, and VI: brief review and guidelines for treatment
Open accessAbstract
Mucopolysaccharidoses (MPS) are rare genetic diseases caused by the deficiency of one of the lysosomal enzymes involved in the glycosaminoglycan (GAG) breakdown pathway. This metabolic block leads to the accumulation of GAG in various organs and tissues of the affected patients, resulting in a multisystemic clinical picture, sometimes including cognitive impairment. Until the beginning of the XXI century, treatment was mainly supportive. Bone marrow transplantation improved the natural course of the disease in some types of MPS, but the morbidity and mortality restricted its use to selected cases. The identification of the genes involved, the new molecular biology tools and the availability of animal models made it possible to develop specific enzyme replacement therapies (ERT) for these diseases. At present, a great number of Brazilian medical centers from all regions of the country have experience with ERT for MPS I, II, and VI, acquired not only through patient treatment but also in clinical trials. Taking the three types of MPS together, over 200 patients have been treated with ERT in our country. This document summarizes the experience of the professionals involved, along with the data available in the international literature, bringing together and harmonizing the information available on the management of these severe and progressive diseases, thus disclosing new prospects for Brazilian patients affected by these conditions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Epidemiology of mucopolysaccharidoses
Khan, S. A., Peracha, H., Ballhausen, D., Wiesbauer, A., Rohrbach, M., Gautschi, M., Mason, R. W., Giugliani, R., Suzuki, Y., Orii, K. E., et al. (2017) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2017.05.016 · Cited by 1,094
Self-citationDesnick, R. J., & Schuchman, E. H. (2012) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-090711-163739 · Cited by 269
ZFN-mediated in vivo genome editing corrects murine hurler syndrome
Ou, L., DeKelver, R. C., Rohde, M., Tom, S., Radeke, R., St. Martin, S. J., Santiago, Y., Sproul, S., Przybilla, M. J., Koniar, B. L., et al. (2019) · Molecular Therapy · doi:10.1016/j.ymthe.2018.10.018 · Cited by 84
Song, L., Bower, J. J., Llanga, T., Salmon, J. H., Hirsch, M. L., & Gilger, B. C. (2020) · Molecular Therapy - Methods & Clinical Development · doi:10.1016/j.omtm.2020.05.014 · Cited by 14
“In the absence of IDUA, GAG accumulation results in enlarged cells and thickened tissues thatmanifest as a progressivemultisystem disease resulting in severe mental retardation, ischemic cardiac disease, ocular abnormalities (including retinopathy, optic nerve damage, and corneal opacity), and usually death in early c…”
Background
Metadata
- Authors
- Giugliani, R., Federhen, A., Muñoz Rojas, M. V., Vieira, T., Artigalás, O., Lapagesse Pinto, L., Azevedo, A. C., Acosta, A., Bonfim, C., Lourenço, C. M., Chong Ae, K., Horovitz, D., Bonfim, D., Norato, D., Marinho, D., Palhares, D., Santos, E. S., Ribeiro, E., Valadares, E., Guarany, F., Lucca, G. R. D., Pimentel, H., Souza, I. N. D., Correa Neto, J., Fraga, J. C., Goes, J. E., Cabral, J. M., Simionato, J., Llerena Jr., J., Jardim, L., Giuliani, L., Silva, L. C. S. D., Santos, M. L., Moreira, M. A., Kerstenetzky, M., Ribeiro, M., Ruas, N., Barrios, P., Aranda, P., Honjo, R., Boy, R., Costa, R., Souza, C., Alcantara, F. F., Avilla, S. G. A., Fagondes, S., & Martins, A. M.
- Venue
- Genetics and Molecular Biology
- Publisher
- FapUNIFESP (SciELO)
- Published
- 2010-11-12
- Volume
- 33
- Issue
- 4
- Pages
- 589-604
- ISSN
- 1415-4757 (ISSN-L)
- 1678-4685
- OpenAlex
- W2158466604
- Cited by
- 188
- References
- 0
- FWCI
- 5.14
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Mucopolysaccharidosis I, II, and VI: brief review and guidelines for treatment. https://app.cochat.ai/papers/10.1590/s1415-47572010005000093
- The paper
- Giugliani, R., Federhen, A., Muñoz Rojas, M. V., Vieira, T., Artigalás, O., Lapagesse Pinto, L., Azevedo, A. C., Acosta, A., Bonfim, C., Lourenço, C. M., Chong Ae, K., Horovitz, D., Bonfim, D., Norato, D., Marinho, D., Palhares, D., Santos, E. S., Ribeiro, E., Valadares, E., . . . Martins, A. M. (2010). Mucopolysaccharidosis I, II, and VI: brief review and guidelines for treatment. Genetics and Molecular Biology. https://doi.org/10.1590/s1415-47572010005000093
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.